-transparent.png){kind=logo}
Cerebral blood flow (CBF) was measured before and after intravenous injection of the cerebral vasodilator nicergoline in 13 patients with cerebrovascular disease. CBF increased in seven. The possibility that the effect of the drug in the remainder may have been masked by a fall of CBF which occurs during sequential measurement of patients at rest is discussed.
Related Publications
L D Iliff, and
G H Du Boulay, and
J Marshall, and
R W Russell, and
L Symon
May 1974,
Il Farmaco; edizione pratica,
L D Iliff, and
G H Du Boulay, and
J Marshall, and
R W Russell, and
L Symon
January 1979,
Arzneimittel-Forschung,
L D Iliff, and
G H Du Boulay, and
J Marshall, and
R W Russell, and
L Symon
January 1967,
Therapia Hungarica (English edition),
L D Iliff, and
G H Du Boulay, and
J Marshall, and
R W Russell, and
L Symon
July 1986,
The American journal of physiology,
L D Iliff, and
G H Du Boulay, and
J Marshall, and
R W Russell, and
L Symon
August 1972,
Arzneimittel-Forschung,
L D Iliff, and
G H Du Boulay, and
J Marshall, and
R W Russell, and
L Symon
March 1987,
Lancet (London, England),
L D Iliff, and
G H Du Boulay, and
J Marshall, and
R W Russell, and
L Symon
October 1985,
The Journal of pharmacology and experimental therapeutics,
L D Iliff, and
G H Du Boulay, and
J Marshall, and
R W Russell, and
L Symon
January 1967,
Taiwan yi xue hui za zhi. Journal of the Formosan Medical Association,
L D Iliff, and
G H Du Boulay, and
J Marshall, and
R W Russell, and
L Symon
January 1989,
Acta neurologica Scandinavica. Supplementum,
L D Iliff, and
G H Du Boulay, and
J Marshall, and
R W Russell, and
L Symon
February 1994,
British journal of anaesthesia,
